10.1016/j.virol.2018.06.011
de Wilde, A. H., Zevenhoven-Dobbe, J. C., van der Meer, Y., Thiel, V.,
Narayanan, K., Makino, S., Snijder, E. J., and van Hemert, M. J. (2011).
Cyclosporin A inhibits the replication of diverse coronaviruses. The
Journal Of General Virology, 92, 2542. doi:10.1099/vir.0.034983-0
Dong, W., Xie, W., Liu, Y., Sui, B., Zhang, H., Liu, L., Tan, Y., Tong,
X., Fu, Z. F., and Yin, P. (2020). Receptor tyrosine kinase inhibitors
block proliferation of TGEV mainly through p38 mitogen-activated protein
kinase pathways. Antiviral Research, 173, 104651. doi:10.1016/j.antiviral.2019.104651
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M.,
Stagliano, N., Donovan, M., Woolf, B., Robison, K., and Jeyaseelan, R.
(2000). A novel angiotensin-converting enzyme-related carboxypeptidase
(ACE2) converts angiotensin I to angiotensin 1-9. Circulation Research,
87, e1-e9. doi:10.1161/01.res.87.5.e1
Elfiky, A. A. and Ibrahim, N. S. (2020). Anti-SARS and Anti-HCV Drugs
Repurposing Against the Papain-like Protease of the Newly Emerged
Coronavirus (2019-nCoV). Research Square, Preprint. doi:10.21203/rs.2.23280/v1
Fehr, A. R. and Perlman, S. (2015). Coronaviruses: an overview of their
replication and pathogenesis in Coronaviruses. Springer, 1282,1-23.doi: 10.1007/978-1-4939-2438-7_1
Gage, P., Ewart, G., Wilson, L., Best, W., and Premkumar, A. (2007).
Antiviral compounds and methods [Google Patents. No,
US20020111382A1]. Retrieved from
https://patents.google.com/patent/US20020111382A1/en
Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun,
Q., Ming, Z., and Zhang, L. (2020). Structure of the RNA-dependent RNA
polymerase from COVID-19 virus. Science, eabb7498. doi: